Nicholas J. Vogelzang - Active Research Support

Active Research Support

Vogelzang is actively involved in many research studies to test new therapies and treatments including:

  • A double-blind, randomised, multiplied dose, Phase III, multicentre study of Alpharadin in the treatment of patients with symptomatic hormone refractory prostate cancer with skeletal metastases. The study began in October 2010 and is supported by Algeta USA.
  • A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy. The study began in March 2010 and is supported by Cougar Biotechnology.
  • A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients with Metastatic Castration-Resistant Prostate Cancer. The study began in April 2009 and is supported by Cougar Biotechnology.
  • A Registry of Sipuleucel-T Therapy in men with advanced prostate Cancer. The study began in June 2010 and is supported by Dendreon.
  • A Phase 1/2., Open label, dose escalation, selected dose comparison trail of TOK-001 for the Treatment of Chemotherapy naïve castration resistant Prostate Cancer. The study began in September 2009 and is supported by Tokai.

Read more about this topic:  Nicholas J. Vogelzang

Famous quotes containing the words active, research and/or support:

    The sense of an entailed disadvantage—the deformed foot doubtfully hidden by the shoe, makes a restlessly active spiritual yeast, and easily turns a self-centred, unloving nature into an Ishmaelite. But in the rarer sort, who presently see their own frustrated claim as one among a myriad, the inexorable sorrow takes the form of fellowship and makes the imagination tender.
    George Eliot [Mary Ann (or Marian)

    If politics is the art of the possible, research is surely the art of the soluble. Both are immensely practical-minded affairs.
    Peter B. Medawar (1915–1987)

    Never support two weaknesses at the same time. It’s your combination sinners—your lecherous liars and your miserly drunkards—who dishonor the vices and bring them into bad repute.
    Thornton Wilder (1897–1975)